Policlinico San Pietro Gruppo San Donato

The medical center is at the forefront of research in paediatric severe eosinophilic asthma, a chronic lung disorder characterized by inflammation of the airways. This condition is marked by elevated levels of eosinophils, a type of white blood cell that exacerbates inflammation, leading to frequent asthma attacks and a decline in lung function.

• Innovative treatments for asthma exacerbations
• Advanced understanding of eosinophil-related inflammation
• Improvement of lung function in paediatric patients

Through cutting-edge research, the center is dedicated to evaluating the efficacy and safety of novel therapies, such as benralizumab, to reduce asthma exacerbations in children and adolescents with uncontrolled asthma. This work is pivotal in enhancing the quality of life for young patients and advancing therapeutic strategies in respiratory medicine.